Dose-range Finding Study of BF2.649 Effect on Patients With Obstructive Sleep Apnea (OSA)

NCT01620554 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Obstructive Sleep Apnoea
Excessive Daytime Sleepiness

Interventions

DRUG: BF2.649
DRUG: BF2.649
DRUG: BF2.649
DRUG: BF2.649
DRUG: Placebo

Sponsor

Bioprojet